MENU
+Compare
PULM
Stock ticker: NASDAQ
AS OF
Nov 13 closing price
Price
$4.89
Change
+$0.01 (+0.20%)
Capitalization
17.86M

PULM Pulmatrix Forecast, Technical & Fundamental Analysis

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE... Show more

Industry: #Biotechnology
PULM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for PULM with price predictions
Nov 12, 2025

PULM in upward trend: 10-day moving average broke above 50-day moving average on October 21, 2025

The 10-day moving average for PULM crossed bullishly above the 50-day moving average on October 21, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 12, 2025. You may want to consider a long position or call options on PULM as a result. In of 100 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

PULM moved above its 50-day moving average on November 11, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PULM advanced for three days, in of 227 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for PULM turned negative on November 04, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PULM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PULM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.774) is normal, around the industry mean (24.439). P/E Ratio (0.000) is within average values for comparable stocks, (63.753). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.001). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. PULM's P/S Ratio (5000.000) is very high in comparison to the industry average of (322.723).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PULM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
PULM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals for pulmonary disease

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
36 Crosby Drive
Phone
+1 781 357-2333
Employees
22
Web
https://www.pulmatrix.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UTMD56.11-0.09
-0.16%
Utah Medical Products
EMBC14.41-0.09
-0.62%
Embecta Corp
VSEC166.59-5.42
-3.15%
VSE Corp
TMDE0.69-0.03
-3.57%
TMD Energy Ltd.
RDDT189.42-13.40
-6.61%
Reddit

PULM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PULM has been loosely correlated with ORMP. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if PULM jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PULM
1D Price
Change %
PULM100%
+0.49%
ORMP - PULM
33%
Loosely correlated
+2.07%
INM - PULM
30%
Poorly correlated
-0.57%
GERN - PULM
27%
Poorly correlated
-0.80%
TSHA - PULM
26%
Poorly correlated
+1.87%
PMVP - PULM
25%
Poorly correlated
+6.77%
More